FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

H J Harkins Company Inc dba Pharma Pac Neomycin 3 Recall

Neomycin 3

H J Harkins Company Inc dba Pharma Pac · Grover Beach, CA

Risk level
Class II
Reported by FDA
Aug 7, 2019
Recall ID
D-1580-2019
Check your lot numberHow we source this data

Summary

H J Harkins Company Inc dba Pharma Pac recalled Neomycin 3 starting Jul 12, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1580-2019 on Aug 7, 2019. Reason: CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility. Status: Terminated.

Why it was recalled

CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.

Product description

Neomycin 3.5 mg/g / Polymyxin B10000 USP Units/g / Dexamethasone 1 mg/g Ophthalmic Ointment, 3.5 g tube, Rx only, Manufactured for H.J. Harkins Company, Inc. dba Pharma Pac by Perrigo Co, Allegan, MI 49010, NDC 52959-0407-01

Lot numbers, UPCs & expiration codes

Lot #: NPD10RP, Exp 08/19; NPD11RP, Exp 09/19; NPD12RP, Exp 11/19; NPD13RP, Exp 02/20; NPD14RP, Exp 02/20; NPD15RP, Exp 05/20; NPD16RP, Exp 06/20; NPD17RP, Exp 01/21; NPD18RP, Exp 02/21

Where it was sold

Distributed in California

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1580-2019
Classification
Class II
Status
Terminated
Recall initiated
Jul 12, 2019
FDA report date
Aug 7, 2019
Quantity
97 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
H J Harkins Company Inc dba Pharma Pac

Original FDA data

Every field from FDA enforcement report D-1580-2019, exactly as published.

Show all FDA fields
City
Grover Beach
State
CA
Status
Terminated
Country
United States
Event ID
83339
Address
1400 W Grand Ave Ste F
Code information
Lot #: NPD10RP, Exp 08/19; NPD11RP, Exp 09/19; NPD12RP, Exp 11/19; NPD13RP, Exp 02/20; NPD14RP, Exp 02/20; NPD15RP, Exp 05/20; NPD16RP, Exp 06/20; NPD17RP, Exp 01/21; NPD18RP, Exp 02/21
Postal code
93433-4221
Report date
Aug 7, 2019
Product type
Drugs
Recall number
D-1580-2019
Classification
Class II
Recalling firm
H J Harkins Company Inc dba Pharma Pac
Product quantity
97 boxes
Termination date
Jun 5, 2023
Reason for recall
CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Neomycin 3.5 mg/g / Polymyxin B10000 USP Units/g / Dexamethasone 1 mg/g Ophthalmic Ointment, 3.5 g tube, Rx only, Manufactured for H.J. Harkins Company, Inc. dba Pharma Pac by Perrigo Co, Allegan, MI 49010, NDC 52959-0407-01
Distribution pattern
Distributed in California
Recall initiation date
Jul 12, 2019
Initial firm notification
Letter
Center classification date
Jul 31, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1580-2019, published Aug 7, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls